Logo image of XOS

XOS INC (XOS) Stock Fundamental Analysis

NASDAQ:XOS - Nasdaq - US98423B3069 - Common Stock - Currency: USD

6  -0.25 (-4%)

After market: 6.1 +0.1 (+1.67%)

Fundamental Rating

3

Overall XOS gets a fundamental rating of 3 out of 10. We evaluated XOS against 129 industry peers in the Machinery industry. The financial health of XOS is average, but there are quite some concerns on its profitability. XOS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year XOS has reported negative net income.
XOS had a negative operating cash flow in the past year.
XOS had negative earnings in 4 of the past 5 years.
In the past 5 years XOS always reported negative operating cash flow.
XOS Yearly Net Income VS EBIT VS OCF VS FCFXOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

XOS has a worse Return On Assets (-37.34%) than 88.80% of its industry peers.
XOS has a Return On Equity of -88.52%. This is amonst the worse of the industry: XOS underperforms 86.40% of its industry peers.
Industry RankSector Rank
ROA -37.34%
ROE -88.52%
ROIC N/A
ROA(3y)-36.45%
ROA(5y)-81.24%
ROE(3y)-73.27%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XOS Yearly ROA, ROE, ROICXOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300 -400

1.3 Margins

The Gross Margin of XOS (14.33%) is worse than 84.00% of its industry peers.
The Profit Margin and Operating Margin are not available for XOS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XOS Yearly Profit, Operating, Gross MarginsXOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -500 -1K

More info and screens

4

2. Health

2.1 Basic Checks

XOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XOS has been reduced compared to 1 year ago.
Compared to 5 years ago, XOS has less shares outstanding
XOS has a better debt/assets ratio than last year.
XOS Yearly Shares OutstandingXOS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 50M 100M 150M
XOS Yearly Total Debt VS Total AssetsXOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -1.90, we must say that XOS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.90, XOS is not doing good in the industry: 78.40% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.01 indicates that XOS is not too dependend on debt financing.
XOS has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. XOS outperforms 80.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -1.9
ROIC/WACCN/A
WACC9.47%
XOS Yearly LT Debt VS Equity VS FCFXOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M

2.3 Liquidity

A Current Ratio of 1.94 indicates that XOS should not have too much problems paying its short term obligations.
XOS has a Current ratio of 1.94. This is comparable to the rest of the industry: XOS outperforms 41.60% of its industry peers.
A Quick Ratio of 1.10 indicates that XOS should not have too much problems paying its short term obligations.
XOS has a Quick ratio of 1.10. This is in the lower half of the industry: XOS underperforms 60.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.1
XOS Yearly Current Assets VS Current LiabilitesXOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

7

3. Growth

3.1 Past

XOS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.78%, which is quite impressive.
Looking at the last year, XOS shows a very strong growth in Revenue. The Revenue has grown by 81.06%.
XOS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 170.05% yearly.
EPS 1Y (TTM)57.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.25%
Revenue 1Y (TTM)81.06%
Revenue growth 3Y156.45%
Revenue growth 5Y170.05%
Sales Q2Q%-5.43%

3.2 Future

Based on estimates for the next years, XOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.22% on average per year.
Based on estimates for the next years, XOS will show a very strong growth in Revenue. The Revenue will grow by 23.04% on average per year.
EPS Next Y60.85%
EPS Next 2Y30.49%
EPS Next 3Y19.22%
EPS Next 5YN/A
Revenue Next Year46.86%
Revenue Next 2Y55.44%
Revenue Next 3Y23.65%
Revenue Next 5Y23.04%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XOS Yearly Revenue VS EstimatesXOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
XOS Yearly EPS VS EstimatesXOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XOS. In the last year negative earnings were reported.
Also next year XOS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XOS Price Earnings VS Forward Price EarningsXOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XOS Per share dataXOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

XOS's earnings are expected to grow with 19.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.49%
EPS Next 3Y19.22%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XOS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOS INC

NASDAQ:XOS (2/21/2025, 8:00:02 PM)

After market: 6.1 +0.1 (+1.67%)

6

-0.25 (-4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-19 2025-03-19/amc
Inst Owners2.8%
Inst Owner Change-1.22%
Ins Owners25.03%
Ins Owner Change0.05%
Market Cap48.18M
Analysts77.5
Price Target9.95 (65.83%)
Short Float %13.93%
Short Ratio18.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.59%
Min EPS beat(2)31.92%
Max EPS beat(2)49.25%
EPS beat(4)3
Avg EPS beat(4)20.5%
Min EPS beat(4)-20.03%
Max EPS beat(4)49.25%
EPS beat(8)5
Avg EPS beat(8)9.4%
EPS beat(12)8
Avg EPS beat(12)11.49%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.23%
Min Revenue beat(2)-31.44%
Max Revenue beat(2)-7.02%
Revenue beat(4)1
Avg Revenue beat(4)-12.21%
Min Revenue beat(4)-31.44%
Max Revenue beat(4)6.73%
Revenue beat(8)2
Avg Revenue beat(8)-17.2%
Revenue beat(12)5
Avg Revenue beat(12)-7.26%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-35%
EPS NQ rev (1m)4.44%
EPS NQ rev (3m)30.43%
EPS NY rev (1m)0%
EPS NY rev (3m)4.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-32.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)-6.08
EYN/A
EPS(NY)-3.9
Fwd EYN/A
FCF(TTM)-6.63
FCFYN/A
OCF(TTM)-6.57
OCFYN/A
SpS7.83
BVpS6.33
TBVpS6.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.34%
ROE -88.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.33%
FCFM N/A
ROA(3y)-36.45%
ROA(5y)-81.24%
ROE(3y)-73.27%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.13%
Cap/Sales 0.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.1
Altman-Z -1.9
F-Score4
WACC9.47%
ROIC/WACCN/A
Cap/Depr(3y)462.77%
Cap/Depr(5y)330.83%
Cap/Sales(3y)46.44%
Cap/Sales(5y)36.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.25%
EPS Next Y60.85%
EPS Next 2Y30.49%
EPS Next 3Y19.22%
EPS Next 5YN/A
Revenue 1Y (TTM)81.06%
Revenue growth 3Y156.45%
Revenue growth 5Y170.05%
Sales Q2Q%-5.43%
Revenue Next Year46.86%
Revenue Next 2Y55.44%
Revenue Next 3Y23.65%
Revenue Next 5Y23.04%
EBIT growth 1Y45.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.94%
EBIT Next 3Y19.33%
EBIT Next 5Y14.42%
FCF growth 1Y65.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.71%
OCF growth 3YN/A
OCF growth 5YN/A